Here are the S-3 shelf registrations from Edesa Biotech, Inc. (EDSA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow EDSA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EDSA filings page.
Edesa Biotech, Inc. registers for resale up to 729,241 common shares issued in a private placement closed June 16, 2026.
The prospectus states these Shares were sold at $4.69 per share to Purchasers (and $5.21 per share to the CEO) for aggregate proceeds of approximately $3.5 million, and that the Company will not receive any proceeds from subsequent resales. Shares outstanding were 9,633,223 as of June 17, 2026.